Clinical Trials Webinar Series - There’s a New PET Drug in Town: Manufacturing and Approval Considerations for Your Institution
Clinical Trials Webinar Series - There’s a New PET Drug in Town: Manufacturing and Approval Considerations for Your Institution
Clinical Trials Webinar Series - There’s a New PET Drug in Town: Manufacturing and Approval Considerations for Your Institution
   

Physician (AMA) Member Fee: Free Non-Member Fee: $29.00
Technologist (VOICE) Member Fee: Free
Non-Member Fee: $29.00
Pharmacist (ACPE) Member Fee: Free / Non-Member Fee: $29.00
Physicist (AMA*) Member Fee: Free Non-Member Fee: $29.00

Release Date: May 7, 2020 Expiration Date: May 31, 2023

Presenter
David W. Dick, PhD

Financial Disclosure 

Name 

Role 

Disclosure 

David W. Dick, PhD

Faculty 

Nothing to Disclose 

Jonathan McConathy, MD, PhD

CTN Co-Chair

Consultant/Advisor for Eli Lilly/Avid, Blue Earth Diagnostics, GE Healthcare and ran Scientific Study/Trials for AbbVie, Navidea, Alphasource and ImaginAb

John Sunderland, PhD, MBA

CTN Co-Chair

Nothing to Disclose 

Michael Graham, PhD, MD 

CTN Co-Chair

Nothing to Disclose 

John Hoffmann, MD 

CTN Education Organizer 

Consultant/Advisor and ran Scientific Study/Trials for GE healthcare and Blue Earth Diagnostics 

Amanda Abbott

Planner/Moderator

Nothing to Disclose 

Bonnie Clark 

Director, SNMMI CTN 

Nothing to Disclose 

Tina Kiss

CTN Staff 

Nothing to Disclose 

Asween Marco

CTN Staff 

Nothing to Disclose 

Bennett Greenspan, MD

CE Reviewer 

Nothing to Disclose 

Arnold M. Strashun, MD 

Chair, Continuing Education Committee 

Nothing to Disclose 

Delicia Hurdle, JD, MBA

SNMMI Staff, Education 

Nothing to Disclose 

No Commercial Support was received for this activity 


In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the planners and faculty have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity. 


Target Audience

Nuclear medicine physicians, pharmacists, technologists, physicists, and residents/students. 


Objectives

1. Describe the difference of using approved drugs under IND or ANDA.
2. Explain the requirements for cost recovery and expanded access INDs.
3. Understand the review timelines for ANDA approval.

Continuing Education Credit Information


To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above.

Physicist (AMA-PRA Category 1 Credits TM):
The Society of Nuclear Medicine and Molecular Imaging Inc., (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.  (Physicians: please access the CE/SAM module by the same title)

SNMMI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. 
* Physicists will receive a certificate stating that this program was accredited for AMA PRA Category 1TM Credit.

Image result for ACPE logo

Pharmacist (ACPE):
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this meeting is 0210-0000-20-027-H04-P.  Total available credit for pharmacists is 1.0 hours or 0.1 CEUs.


Technologist (VOICE A+):

The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. California Scope: 1.0 Non-Imaging (I).

This is also available as a non-credit activity for Students.

Minimum system requirements 

- Supported Internet Browsers: 
- Microsoft Internet Explorer (version 7 or higher) 
- Google Chrome (latest version) 
- Mozilla Firefox (latest version) 
- Apple Safari (version 4 or higher) 
 

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)  
 
For questions please contact the Education Department 703-708-9000 x1. 
© 2020 SNMMI. All rights reserved.  
 
For more information on our privacy policy, please click the link below. 


Type:     Internet Activity (Enduring Material)
120 Registered Users